Publication:
Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2.

Loading...
Thumbnail Image

Date

2021-01-29

Authors

Miro, Oscar
Llorens, Pere
Jimenez, Sonia
Piñera, Pascual
Burillo-Putze, Guillermo
Martin, Alfonso
Martin-Sanchez, Francisco Javier
Gonzalez-Del-Castillo, Juan

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Infection by SARS-CoV-2 is mainly characterized by fever and respiratory symptoms, with dyspnea and lung infiltrates in more severe cases. Many patients also present a pro-coagulant state, which is biochemically detected by increased D-dimer levels and is related to complications and a worse prognosis. In this context, isolated case reports and short case series have suggested an increased risk of patients with COVID-19 developing clinically relevant cardiovascular and hemostatic disturbances. Nonetheless, many of these reports refer to hospitalized patients, and as hospitalization itself usually increases complications in bedridden patients with multidrug treatment or in very poor condition, it is unknown if such cardiovascular/hemostatic processes are related to the pathogenesis of SARS-CoV-2. Focusing on patients with COVID-19 at emergency department (ED) arrival could help answer this question.

Description

MeSH Terms

Acute Coronary Syndrome
Aged
Aged, 80 and over
COVID-19
Cardiovascular Diseases
Case-Control Studies
Female
Gastrointestinal Hemorrhage
Hemostasis
Humans
Male
Middle Aged

DeCS Terms

Hemostáticos
Infecciones
Disnea
Fiebre
Coagulantes
Servicio de Urgencia en Hospital

CIE Terms

Keywords

Área Sanitaria Norte de Córdoba, Pulmonary Embolism, Retrospective Studies, Stroke, Venous Thrombosis

Citation

Miró Ò, Llorens P, Jiménez S, Piñera P, Burillo-Putze G, Martín A, et al. Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2. Int J Cardiol. 2021 May 1;330:268-272